🇺🇸 FDA
Patent

US 7951543

Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype

granted A61PA61P25/18

Quick answer

US patent 7951543 (Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype) held by SureGene LLC expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SureGene LLC
Grant date
Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P25/18